PetMed Express, Inc.
PETS
$2.74
-$0.01-0.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.47M | 52.98M | 59.57M | 67.95M | 59.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.47M | 52.98M | 59.57M | 67.95M | 59.54M |
| Cost of Revenue | 27.52M | 38.08M | 42.26M | 49.98M | 35.24M |
| Gross Profit | 18.95M | 14.91M | 17.31M | 17.97M | 24.30M |
| SG&A Expenses | 30.83M | 13.77M | 14.79M | 10.52M | 25.61M |
| Depreciation & Amortization | 2.07M | 1.59M | 1.66M | 1.72M | 1.90M |
| Other Operating Expenses | -1.18M | -- | -- | -- | -1.09M |
| Total Operating Expenses | 59.25M | 53.43M | 58.71M | 62.22M | 61.66M |
| Operating Income | -12.78M | -450.00K | 859.00K | 5.74M | -2.12M |
| Income Before Tax | -5.98M | -242.00K | 925.00K | 4.71M | -3.48M |
| Income Tax Expenses | 5.66M | 465.00K | -1.40M | 958.00K | 1.54M |
| Earnings from Continuing Operations | -11.64M | -707.00K | 2.33M | 3.75M | -5.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.64M | -707.00K | 2.33M | 3.75M | -5.02M |
| EBIT | -12.78M | -450.00K | 859.00K | 5.74M | -2.12M |
| EBITDA | -10.71M | 1.14M | 2.52M | 7.46M | -1.23M |
| EPS Basic | -0.56 | -0.03 | 0.11 | 0.18 | -0.25 |
| Normalized Basic EPS | -0.39 | -0.01 | 0.04 | 0.18 | -0.05 |
| EPS Diluted | -0.56 | -0.03 | 0.11 | 0.18 | -0.25 |
| Normalized Diluted EPS | -0.39 | -0.01 | 0.04 | 0.18 | -0.05 |
| Average Basic Shares Outstanding | 20.64M | 20.63M | 20.60M | 20.51M | 20.44M |
| Average Diluted Shares Outstanding | 20.64M | 20.63M | 20.94M | 20.94M | 20.44M |
| Dividend Per Share | -- | -- | -- | -- | 0.00 |
| Payout Ratio | -0.04% | -0.14% | 3.05% | 2.77% | -0.36% |